Biron et al., Glycobiology 2006
(Sertoli-Leydig Cell Tumor...) :
These pathways were independently activated, as the presence of the inhibitor of caspase-8 or -9 only partially prevented Gal-1-effect Schultz et al., Journal of ovarian research 2013
:
We show that forced expression of ST6Gal-I in OV4 ovarian cancer cells that lack endogenous ST6Gal-I causes reduced activation of caspase 3 and increased cell viability following cisplatin treatment